论文部分内容阅读
近年早孕需流产妇女增多,使流产后宫内残留情况也时有发生,残留者常需再次刮宫,由此引起痛苦与不良反应,笔者应用雌孕激素行药物性刮宫治疗,使大部分宫内少量残留者避免第二次刮宫,报告如下。1 临床资料 1999年8月至12月本院就诊的宫内少量残留患者8例,年龄最小21岁,最大35岁,平均25岁,其中药流与人流各4例,均为流产后半月阴道出血不止且B超证实宫内残留,残留物大小:0.5cm×0.5cm左右5例,1cm×1cm左右3例,均用乙芪酚又称乙烯雌酚、黄体酮药物口服治疗观察效果。
In recent years, the number of abortions in early pregnancy increased, so that the residual intrauterine abortion also occur from time to time, residual often need to curettage, resulting in pain and adverse reactions, the author of estrogen and progesterone medication curettage, so that most of the intrauterine A small number of residual to avoid the second curettage, the report is as follows. 1 Clinical data August 1999 to December a small amount of residual intrauterine treatment of patients in our hospital 8 cases, the youngest 21 years old, maximum 35 years old, average 25 years old, of which the drug flow and the flow of 4 cases, both abortion vaginal bleeding after half a month More than B and confirmed intrauterine residue, residue size: 0.5cm × 0.5cm around 5 cases, 1cm × 1cm around 3 cases, both with diethylstilbestrol, also known as diethylstilbestrol, progesterone oral treatment of observation.